Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions

Vaccine

Volumn 28, Issue 5, 2010, Pages 1241-1252

  Goswami, Shyamal ^a   Bose, Anamika ^a   Sarkar, Koustav ^a   Roy, Soumyabrata ^a   Chakraborty, Tathagata ^a   Sanyal, Utpal ^a   Baral, Rathindranath ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Carcinoembryonic antigen; Dendritic cells; Neem leaf glycoprotein

Indexed keywords

AZADIRACHTA INDICA EXTRACT; B7 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD14 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AZADIRACHTA INDICA; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MICROENVIRONMENT; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PLANT LEAF; PRIORITY JOURNAL; SOLID TUMOR; T LYMPHOCYTE; TUMOR IMMUNITY; UPREGULATION;

ANIMALS; ANTIGENS, CD; AZADIRACHTA; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MONOCYTES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PLANT LEAVES; PLANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 74249100607     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.018     Document Type: Article

References (50)

1. Liu Y.J., Holger K., Vassili S., and Gilliet M. Dendritic cell lineage, plasticity and cross regulation. Nat Immunol 2 7 (2001) 585-589
2. Josien R., Li H.L., Ingulli E., Sarma S., Wong B.R., Vologodskaia M., et al. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med 191 3 (2000) 495-502
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
4. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
5. Cellia M., Saliustro F., and Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9 1 (1997) 10-16
6. Brittingham K.C., Ruthel G., Panchal R.G., Fuller C.L., Ribot W.J., Hoover T.A., et al. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol 174 9 (2005) 5545-5552
7. + dendritic cells in mice deficient for IFN regulatory factor-2. Proc Natl Acad Sci USA 101 11 (2004) 3909-3914
8. Reis e Sousa C., Sher A., and Kaye P. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr Opin Immunol 11 4 (1999) 392-399
9. Moser M., and Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1 3 (2001) 199-205
10. Banchereau J., and Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5 4 (2005) 296-306
11. Nestle F.O., Banchereau J., and Hart D. Dendritic cells: on the move from bench to bedside. Nat Med 7 7 (2001) 761-765
12. Reddy S.T., Swartz M.A., and Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 27 12 (2006) 573-579
13. Labeur M.S., Roters B., Pers B., Nehling A., Luger T.A., Schwarz T., et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 162 1 (1999) 168-175
14. Satthaporn S., Aloysius M.M., Robins R.A., Verma C., Chuthapisith S., McKechnie A.J., et al. Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha. BMC Immunol 9 (2008) 32-46
15. Trevejo J.M., Marino M.W., Philpott N., Josian R., Richards E.C., Elkon K.B., et al. TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci USA 98 21 (2001) 12162-12167
16. Brasel K., De Smedt T., Smith L.J., and Maliszewski C.R. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96 9 (2000) 3029-3039
17. Hartmann G., Weiner G., and Kreig A.M. CpG DNA as a signal for growth, activation and maturation of human dendritic cells. Proc Natl Acad Sci USA 96 16 (1996) 9305-9310
18. Weigel B.J., Nath N., Taylor P.A., Panoskaltsis-Mortari A., Chen W., Krieg A.M., et al. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of anti-leukemia responses. Blood 100 12 (2002) 4169-4176
19. Friedberg J.W., Kim H., McCauley M., Hessel E.M., Sims P., Fisher D.C., et al. IRAK1 serves as a novel regulator essential for LPS-induced IL-10 gene expression. J Biol Chem 279 49 (2004) 51697-51703
20. Friedberg J.W., Helen K., McCauley M., et al. Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-/-inducible gene expression, without significant toxicity. Blood 105 2 (2005) 489-495
21. Bose A., and Baral R.N. NK cellular cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L mediated endogenous production of IL-12. Hum Immunol 68 10 (2007) 823-831
22. Baral R.N., and Chattopadhyay U. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Int Immunopharmacol 4 3 (2004) 355-366
23. Mandal-Ghosh I., Chattopadhyay U., and Baral R.N. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immunity 7 (2007) 8-17
24. Sarkar K., Bose A., Chakraborty K., Haque E., Ghosh D., Goswami S., et al. Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation. Vaccine 26 34 (2008) 4352-4362
25. Chakraborty K., Bose A., Pal S., Sarkar K., Goswami S., Ghosh D., et al. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance. Int Immunopharmacol 8 2 (2008) 330-340
26. Baral R.N., and Maity P. Induction of colorectal cancer in rats by 20-methylcholanthrene. Cancer Lett 61 2 (1992) 177-183
27. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factors. J Exp Med 176 6 (1992) 1693-1702
28. Bayry J., Lacroix-Desmazes S., Donkova-Petrini V., Carbonneil C., Misra N., Lepelletier Y., et al. Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci USA 101 39 (2004) 14210-14215
29. Heufler C., Koch F., Stanzl U., Topar G., Wysocka M., Trinchieri G., et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur J Immunol 26 3 (1996) 659-668
30. Movassagh M., Laderach D., and Galy A. Proteins of the Ikaros family control dendritic cell maturation required to induce optimal Th1 T cell differentiation. Int Immunol 16 6 (2004) 867-875
31. Bose A., Chakraborty K., Sarkar K., Goswami S., Chakraborty T., Pal S., et al. Neem leaf glycoprotein induces perforin mediated tumor cell killing by T and NK cells through differential regulation of IFNγ signaling. J Immunother 32 1 (2009) 42-53
32. Bose A., Haque E., and Baral R.N. Neem leaf preparation induces apoptosis of tumor cells by releasing cytotoxic cytokines from human peripheral blood mononuclear cells. Phytother Res 21 10 (2007) 914-920
33. Bose A., Chakraborty K., Sarkar K., Goswami S., Haque E., Chakraborty T., et al. Neem leaf glycoprotein directs T-bet associated Th1 type immune commitment. Hum Immunol 70 1 (2009) 6-15
34. Hill M., Tanguy-Royer S., Royer P., Chauveau C., Asghar K., Tesson L., et al. IDO expands human CD4 + CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol 37 11 (2007) 3054-3062
35. MacDonald A.S., and Maizels R.M. Alarming dendritic cells for Th2 induction. J Exp Med 205 1 (2008) 13-17
36. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 9 (2000) 1213-1222
37. Banerjee D.K., Dhodapkar M.V., Matayeva E., Steinman R.M., and Dhodapkar K.M. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108 8 (2006) 2655-2661
38. Haque E., Mandal I., Pal S., and Baral R. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory. Immunopharmacol Immunotoxicol 28 1 (2006) 33-50
39. Kalinski P., and Moser M. Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses. Nat Rev Immunol 5 3 (2005) 251-260
40. Roy K.C., Bandopadhyay G., Rakshit S., Ray M., and Bandopadhyay S. IL4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset. J Cell Sci 117 16 (2004) 3435-3445
41. Huang J., Tatsumi T., Pizzoferrato E., Vujanovic N., and Storkus W.J. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation. Cancer Res 65 18 (2005) 8461-8470
42. Hackstein H., Taner T., Logar A.J., and Thomson A.W. Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood 100 3 (2002) 1084-1087
43. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 103 28 (2006) 10729-10734
44. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315 5808 (2007) 107-111
45. den Haan J.M., Lehar S.M., and Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192 12 (2000) 1685-1696
46. Wu L., Nichogiannopoulou A., Shortman K., and Georgopoulos K. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7 4 (1997) 483-492
47. Kaliński P., Hilkens C.M., Wierenga E.A., van der Pouw-Kraan T.C., van Lier R.A., Bos J.D., et al. Functional maturation of human naive T helper cells in the absence of accessory cells. J Immunol 154 8 (1995) 3753-3760
48. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.Y., Rennert P.D., et al. B7-1 and B7-2 do not deliver identical co-stimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2 5 (1995) 523-532
49. Brunner C., Seiderer J., Schlamp A., Bidlingmaier M., Eigler A., Haimerl W., et al. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol 165 11 (2000) 6278-6286
50. Baral R.N., Saha A., Chatterjee S.K., Foon K.A., Krieg A.M., Weiner G.J., et al. Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen. Cancer Immunol Immunother 52 5 (2003) 317-327